November 2012 FDA Recall Drug by Caraco Pharmaceutical Laboratories, Ltd.
D-089-2013 - Adulterated Presence of Foreign Tablets

This Class II drug recall was voluntarily initiated by Caraco Pharmaceutical Laboratories, Ltd. on November 5, 2012 for the product Drug. The FDA reported the reason for recall as adulterated presence of foreign tablets. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-089-2013

Reason for Recall
Adulterated Presence of Foreign Tablets: A customer complaint was received that a bottle of Tramadol HCl Tablets USP 50 mg contained some tablets of Metoprolol Tartrate Tablets USP, 50 mg.
Initiated
11-05-2012
Reported
12-12-2012
Quantity
2,264 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Caraco Pharmaceutical Laboratories, Ltd.
traMADOL Hydrochloride Tablets, USP 50 mg, 1000-count tablets per bottle, Manufactured by: Sun Pharmaceuticals Industries, Dadra 396 191, India; Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; NDC 57664-377-18.

Batch or Lot Expiration Information

Lot# GKK1373, Exp 09/13